Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The revision tag in the page footer updates from v3.6.2 to v3.6.3, signaling a new UI release without altering the study record content.
    Difference
    0.0%
    Check dated 2026-07-04T04:57:21.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A new site revision label v3.6.2 was added and the previous v3.6.0 entry was removed from the history display.
    Difference
    0.0%
    Check dated 2026-06-27T03:08:05.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Recruitment status now shows 'No longer looking for participants', clarifying that the study is not enrolling. The revision label has updated to v3.6.0, with v3.5.5 removed.
    Difference
    0.1%
    Check dated 2026-06-12T16:32:26.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page history now shows Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a minor update to the page's metadata or rendering without altering core content.
    Difference
    0.0%
    Check dated 2026-06-05T13:16:46.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The Record History section now reflects a newer revision (v3.5.4) and no longer shows v3.5.3, indicating a page update to the version label.
    Difference
    0.0%
    Check dated 2026-05-15T05:22:36.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page’s software/UI revision label is updated from `v3.5.2` to `v3.5.3`, indicating a minor technical release of the ClinicalTrials.gov interface rather than a modification to the underlying study record.
    Difference
    0.0%
    Check dated 2026-04-24T05:58:58.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.